ClinicalTrials.govpublic full text
Trial of Topotecan With VX-970 (M6620), an ATR Kinase Inhibitor, in Small Cell Cancers and Extrapulmonary Small Cell Cancers
carcinoma, non-small -cell lung, ovarian neoplasms, small cell lung carcinoma, uterine cervical neoplasms, carcinoma, neuroendocrine, extrapulmonary small cell cancer, rb1 inactivation, kinase inhibitor, dna damage response network, myc and ccne1 activation, defective atm-p53 signaling pathway, interventional
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 882356
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.